The Legislative Budget Board (LBB) indicates that HB 1612 is not expected to have a significant fiscal impact on the state. The analysis assumes that any administrative costs necessary to implement the bill—such as updating hospital billing systems or clarifying payment procedures—can be absorbed by relevant agencies using existing resources.
Additionally, the fiscal note concludes that there would be no financial impact on local governments. Since the bill primarily affects the transactional relationship between individual patients and hospitals, and does not mandate any new programs, benefits, or infrastructure for state or local agencies, it does not require appropriations or result in new costs for governmental units.
The analysis included input from a range of state agencies, such as the Health and Human Services Commission, Department of Insurance, Teacher Retirement System, and public university systems, all of which confirmed that their operations would not be materially affected. In summary, while the bill may shift healthcare billing practices, particularly by expanding the option of direct patient payments, it does so in a manner that avoids significant fiscal consequences for the state or its subdivisions.
HB 1612 addresses a longstanding concern in healthcare billing: the significant pricing disparities hospitals may impose on uninsured patients compared to insured ones. The bill creates a legal framework allowing uninsured patients to request and make direct payments to hospitals, while also establishing clear pricing caps to protect these patients from arbitrary or excessively high charges. The legislative intent, as noted in the bill analysis, is to address inconsistencies in hospital billing practices and to offer a more equitable system for individuals without health insurance.
The committee substitute improves upon the originally filed version by offering hospitals greater flexibility in pricing, while maintaining important consumer protections. Rather than a strict cap of 25% above the lowest contracted commercial rate (as in the introduced version), the substitute allows hospitals to use one of two benchmarks: up to 25% above their "generally billed" amount (per IRS guidelines), or up to 50% above the lowest contracted rate from a commercial payer. This compromise better balances the goals of protecting patients from predatory pricing while acknowledging hospitals' varying cost structures and reimbursement needs.
There are no anticipated significant fiscal implications for the state or local governments, and no additional rulemaking authority is required to implement the legislation. Furthermore, the bill does not create any criminal offenses or regulatory burdens, supporting the principle of limited government. From a policy standpoint, HB 1612 advances individual liberty by empowering patients to control their healthcare transactions and promotes transparency in healthcare pricing. Texas Policy Research recommends that lawmakers vote YES on HB 1612.